CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma

SIMPLE SUMMARY: CD229 is a cell-surface molecule predominantly expressed on lymphocytes. Its expression in B-cell malignancies is poorly known. We tested the presence of this immunoreceptor on a large number of malignancies and normal tissue using a new monoclonal antibody and tissue microarrays. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Roncador, Giovanna, Puñet-Ortiz, Joan, Maestre, Lorena, Rodríguez-Lobato, Luis Gerardo, Jiménez, Scherezade, Reyes-García, Ana Isabel, García-González, Álvaro, García, Juan F., Piris, Miguel Ángel, Montes-Moreno, Santiago, Rodríguez-Justo, Manuel, Mena, Mari-Pau, Fernández de Larrea, Carlos, Engel, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101303/
https://www.ncbi.nlm.nih.gov/pubmed/35565280
http://dx.doi.org/10.3390/cancers14092154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101303/
https://www.ncbi.nlm.nih.gov/pubmed/35565280
http://dx.doi.org/10.3390/cancers14092154

Ejemplares similares